ANOVA
WaktuPerdarahan Sum of Squares
df Mean Square
F Sig.
Between Groups 405761.375
3 135253.792
11.470 .000
Within Groups 330161.500
28 11791.482
Total 735922.875
31
UJI KRUSKAL WALLIS
Test Statistics
a,b
WaktuPerdaraha n
Chi-Square 18.586
df 3
Asymp. Sig. .000
a. Kruskal Wallis Test b. Grouping Variable: NamaObat
UJI MANN WHITNEY Placebo dan Aspirin
Ranks
NamaObat N
Mean Rank Sum of Ranks
WaktuPerdarahan Placebo
8 4.50
36.00 Aspirin
8 12.50
100.00 Total
16
Universitas Sumatera Utara
Test Statistics
a
WaktuPerdaraha n
Mann-Whitney U .000
Wilcoxon W 36.000
Z -3.363
Asymp. Sig. 2-tailed .001
Exact Sig. [21-tailed Sig.] .000
b
a. Grouping Variable: NamaObat b. Not corrected for ties.
Placebo dan Propolis
Ranks
NamaObat N
Mean Rank Sum of Ranks
WaktuPerdarahan Placebo
8 4.50
36.00 Propolis
8 12.50
100.00 Total
16
Test Statistics
a
WaktuPerdaraha n
Mann-Whitney U .000
Wilcoxon W 36.000
Z -3.363
Asymp. Sig. 2-tailed .001
Exact Sig. [21-tailed Sig.] .000
b
a. Grouping Variable: NamaObat b. Not corrected for ties.
Universitas Sumatera Utara
Placebo dan Madu
Ranks
NamaObat N
Mean Rank Sum of Ranks
WaktuPerdarahan Placebo
8 4.50
36.00 Madu
8 12.50
100.00 Total
16
Test Statistics
a
WaktuPerdaraha n
Mann-Whitney U .000
Wilcoxon W 36.000
Z -3.363
Asymp. Sig. 2-tailed .001
Exact Sig. [21-tailed Sig.] .000
b
a. Grouping Variable: NamaObat b. Not corrected for ties.
Aspirin dan Propolis
Ranks
NamaObat N
Mean Rank Sum of Ranks
WaktuPerdarahan Aspirin
8 8.25
66.00 Propolis
8 8.75
70.00 Total
16
Universitas Sumatera Utara
Test Statistics
a
WaktuPerdaraha n
Mann-Whitney U 30.000
Wilcoxon W 66.000
Z -.210
Asymp. Sig. 2-tailed .834
Exact Sig. [21-tailed Sig.] .878
b
a. Grouping Variable: NamaObat b. Not corrected for ties.
Aspirin dan Madu
Ranks
NamaObat N
Mean Rank Sum of Ranks
WaktuPerdarahan Aspirin
8 10.13
81.00 Madu
8 6.88
55.00 Total
16
Test Statistics
a
WaktuPerdaraha n
Mann-Whitney U 19.000
Wilcoxon W 55.000
Z -1.365
Asymp. Sig. 2-tailed .172
Exact Sig. [21-tailed Sig.] .195
b
a. Grouping Variable: NamaObat b. Not corrected for ties.
Universitas Sumatera Utara
Propolis dan Madu
Ranks
NamaObat N
Mean Rank Sum of Ranks
WaktuPerdarahan Propolis
8 9.75
78.00 Madu
8 7.25
58.00 Total
16
Test Statistics
a
WaktuPerdaraha n
Mann-Whitney U 22.000
Wilcoxon W 58.000
Z -1.050
Asymp. Sig. 2-tailed .294
Exact Sig. [21-tailed Sig.] .328
b
a. Grouping Variable: NamaObat b. Not corrected for ties.
Universitas Sumatera Utara
DAFTAR PUSTAKA
Ahmed, A., et al., 2011. Effect of Natural Honey on Human Platelets and Blood Coagulation Proteins. Pak. J. Pharm. Sci., 24 3: 389-397.
Akhlaghi, M., Bandy, B., 2009. Mechanisms of flavonoid protection against myocardial ischemia-reperfusion injury. Journal of Molecular and Cellular
Cardiology , 46: 309-317.
Alvarez-Suarez, J.M., Gasparrini, M., Forbes-Hernández, T.Y., Mazzoni, L., Giampieri, F., 2014. Review: The Composition and Biological Activity of
Honey: A Focus on Manuka Honey. Foods, 3: 420-432. Antithrombotic Trialists’ Collaboration, 2002. Collaborative meta-analysis of
randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. British Medical Journal, 324: 71-86.
Barrett, K.E., Barman, S.M., Boitano, S., Brooks, H.L., 2012. Blood as a Circulatory Fluids the Dynamics of Blood Lymph Flow. Dalam:
Ganong’s Review of Medical Physiology. 24
th
ed. USA: McGraw-Hill, 565. Bogdanov, S., Jurendic, T., Sieber, R., Gallmann, P., 2008. Honey for nutrition and
health: A review. J. Am. Coll. Nutr., 27: 677-689. Bojic, M., Debeljak, Z., Tomicic, M., Medic-Saric, M., Tomic, S., 2011. Evaluation
of antiaggregatory activity of flavonoid aglycone series. Nutrition Journal, 10: 73.
Castro, S.L., 2001. Propolis: Biological and Pharmacological Activities. Therapeutic Uses of this Bee-product. ARBS Annual Rev. Biomed. Sci., 3: 49-83.
Universitas Sumatera Utara
Chen, T., et al., 2007. Antiplatelet Activity of Caffeic Acid Phenethyl Ester Is Mediated through a Cyclic GMP-Dependent Pathway in Human Platelets.
Chinese Journal of Physiology, 50 3: 121-126. Codex Stan 12-1981. Revised Codex Standard for Honey. Codex Stan 12-1981,
Rev. 1 1987, Rev. 2 2001. Diunduh dari: www.codexalimentarius.orginputdownloadstandards310cxs_012e.pdf.
[Diakses pada 5 April 2015]. Eteraf-Oskouei, T., Najafi, M., 2013. Traditional and Modern Uses of Natural Honey
In Human Diseases: A Review. Iran J Basic Med Sci, 16: 731-742. Farooqui, T., 2009. Honey: An Anti-Aging Remedy to Keep you Healthy in a Natural
Way . Diunduh dari:
http:www.scienceboard.netcommunityperspectives.228.html. [Diakses pada 23 May 2015].
Farooqui, T., Farooqui, A.A., 2014. Honey for Cardiovascular Disease. Dalam: Boukraa, L., 2014. Honey in Traditional and Modern Medicine. USA: Taylor
Francis Group, 187-216. Farrugia, C.A., 1999. The Antiplatelet Activity of Aspirin. The chronic ill, 3: 14-18.
Federer, W.Y., 1963. Experimental Design, Theory and Application. New York: Mac. Millan: 544.
Ferroni, P., Basili, S., Falco, A., Davi, G., 2004. Oxidant stress and platelet activation in hypercholesterolemia. Antioxid. Redox. Signal, 6 4: 747-756.
Gomez-Caravaca, A.M., Gomez-Romero, M., Arraez-Roman, D., Segura-Carretero, A., Fernandez-Gutierrez, A., 2006. Advances in the analysis of phenolic
compounds in products derived from bees. Journal of Pharmaceutical and Biomedical Analysis, 41: 1220-1234.
Universitas Sumatera Utara
Havsteen, B.H., 2002. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther., 96: 67-202.
Hegazi, A.G., El-Hady, F.K.A., 2009. Influence of Honey on the Suppression of Human Low Density Lipoprotein LDL Peroxidation In vitro. eCAM, 6 1:
113-121. Howland, R.D., Mycek, M.J., 2006. Drugs Affecting The Blood. Dalam:
Lippincott’s Illustrated Reviews: Pharmacology
. 3
rd
ed. USA: Williams Wilkins, 227-244. Ivashchenko, M.N., Samodelkin, A.G., 2014. Effect of Propolis on Platelet
Aggregation. Biological Sciences. Fundamental Research, 12: 2146-2149. Jin, Y., 2007. Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated
by inhibition of PLC- γ2 phosphorylation and cyclooxygenase-1 activity.
Atherosclerosis, 194: 144-152. Krell, R., 1996. Honey. Value Added Products From Beekeeping. FAO Agricultural
Services Bulletin. Food and Agriculture Organization of the United Nation. 124: 16-23.
Krell, R., 1996. Propolis. Value Added Products From Beekeeping. FAO Agricultural Services Bulletin. Food and Agriculture Organization of the United Nation. 124:
153-157. Laurence, D.R., Bacharach, A.L., 1964. Evaluation of drug activities:
Pharmacometrics . New York: Academic Press, 1: 196.
Litovitz, T.L., et al., 2001. Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. American Journal of
Emergency Medicine, 20 5: 337-395.
Universitas Sumatera Utara
Longo, D.L., et al., 2012. Arterial and Venous Thrombosis. Dalam: Harrison’s
Principles of Internal Medicine . 18
th
ed. USA: McGraw-Hill, 117. Ndagu, L.F., Arjana, A.A., Berata, I.K., 2013. Madu Berefek Protektif Terhadap
Infiltrasi Sel Radang dan Perdarahan Ginjal Akibat Induksi Aspirin. Indonesia Medicus Veterinus, 2 1: 102-114.
OECDWHO, 2014. Mortality from cardiovascular disease. In: Health at a Glance: AsiaPacific 2014: Measuring Progress towards Universal Health Coverage
, OECD Publishing: 22-23.
Olaitan, P.B., Adeleke, O.E., Ola, I.O., 2007. Honey: a reservoir for microorganisms and an inhibitory agent for microbes. African Health Sciences, 7 3: 159-165.
Patrono, C., et al., 2004. Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects. The Seventh ACCP Conference on
Antithrombotic and Thrombolytic Therapy. CHEST, 126 3: 234S-264S. Rang, H.P., Dale, M.M., Ritter, J.M., Flower, R.J., Henderson, G., 2012. Haemostasis
and thrombosis. Dalam: Rang Dale’s Pharmacology. 7
th
ed. Spain: 294-308. Rosmiati, H., Gan, V.H.S., 1995. Antikoagulan, Antitrombosit, Trombolitik dan
Hemostatik. Dalam: Ganiswara, S.G., Setiabudy, R., Suyatna, F.D., Purwantyastuti, 1995. Farmakologi dan Terapi, edisi ke-4. Jakarta: Gaya Baru,
747-761. Salatino, A., Teixeira, E.W., Negri, G., Message, D., 2005. Review: Origin and
Chemical Variation of Brazilian Propolis. eCAM, 2 1: 33-38. Suharti, C., 2009. Dasar-dasar Hemostasis. Dalam: Sudoyo, A.W., Setiyohadi, B.,
Alwi, I., Simadibrata, M., Setiati, S., 2009. Ilmu Penyakit Dalam, edisi ke-5, Jilid II. Jakarta: 1293-1300.
Universitas Sumatera Utara
Tambunan, K.L., 2009. Patogenesis Trombosis. Dalam: Sudoyo, A.W., Setiyohadi, B., Alwi, I., Simadibrata, M., Setiati, S., 2009. Ilmu Penyakit Dalam,
edisi ke-5, Jilid II. Jakarta: 1301-1306. Tortora, G.J., Derrickson, B., 2011. The Cardiovascular System: The Blood. Dalam:
Principles of Anatomy Physiology: Maintenance and Continuity of the Human Body. 13
th
ed. Volume 2. Asia: John Wiley Sons, Inc., 728-756. Tripathi, K.D., 2008. Nonsteroidal Antiinflammatory Drugs and Antipyretic-
Analgesics. Dalam: Essentials of Medical Pharmacology. 6
th
ed. New Delhi: Jaypee Brothers Medical Publishers, 187-189.
WHO, 2007. Prevention of Cardiovascular Disease: Pocket Guidelines for Assessment and Management of Cardiovascular Risk: WHOISH Cardiovascular
Risk Prediction
Charts for
the African
Region. Diunduh
dari: http:www.who.intcardiovascular_diseasesguidelinesPocketGL.ENGLISH.
AFR-D-E.rev1.pdf. [Diakses pada 23 April 2015]. WHO,
2012. NCD
mortality and
morbidity .
WHO. Diunduh
dari: http:www.who.intghoncdmortality_morbidityen.
[Diakses pada
14 April 2015].
WHO-Noncommunicable Diseases NCD Country Profiles, 2014. Indonesia. Diunduh
dari: www.who.intnmhcountriesidn_en.pdf.
[Diakses pada
24 April 2015].
Universitas Sumatera Utara
BAB 3 KERANGKA KONSEP DAN DEFINISI OPERASIONAL
3.1. Kerangka Konsep Penelitian
